Skip to main content
. 2010 Feb 15;133(3):771–786. doi: 10.1093/brain/awq007

Table 4.

Summary of OPA1 mutations and molecular profile identified in patients with DOA+ phenotypes

OPA1 mutations
Missense Nonsense Splice site Deletion
DOA + patients n 80 3 8 13
COX-deficiencya 1 3 2
+ 17 1 2 2
MtDNA deletionsa 2 2
+ 18 1 3 2

aFor DOA+ patients where muscle biopsies were available for histochemical and molecular analysis (n = 28).